Delivery Order SPE2DB22D9244-SPE2DB25FZS78
Award Date 9/16/25
Potential Completion Date 10/7/25
Potential Value $7.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,084.36 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is not associated with a set-aside designation and carries an ultimate completion date of August 25, 2025. The award represents a single line item delivery under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,313.27 by the Defense Logistics Agency (DLA) on August 19, 2025. The delivery order covers the supply of Actemra 400 mg/20 mL vials, a biologic medication used primarily for treating rheumatoid arthritis and other inflammatory conditions. This award was issued without a set-aside designation and is scheduled for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,318.25 by the Defense Logistics Agency (DLA) on May 2, 2025. The contract, which carries no set-aside designation, calls for delivery of Actemra 162 mg/0.9 ml syringes with an ultimate completion date of May 23, 2025. Actemra (tocilizumab) is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $9,273.12 for the supply of Actemra Actpen 162 mg/0.9 ml injection pens. The award, issued on May 12, 2025, with an ultimate completion date of June 3, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,923.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with an ultimate completion date of April 25, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 and held by DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,385.04 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564299269 - Actemra Actpen 162 mg/0.9 ml 0.9ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FYW67) between DMS Pharmaceutical Group and DLA, valued at up to...
- The Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order worth $14,003.64 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The delivery order is for 4556446218 - ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,903.32 firm fixed-price delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, with a completion date of December 14, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,884.92 contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,192.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a biologic medication used to treat certain autoimmune conditions. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA, which...